2 Beaten-Down Growth Stocks to Buy Hand Over Fist
September wasn't a great month on Wall Street. The S&P 500 dropped almost 5%, and plenty of stocks performed significantly worse. For instance, shares of biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) fell about 8% while cloud computing company Veeva Systems (NYSE: VEEV) saw its stock plunge nearly 14%.
But if you intend to hold the shares of companies for five years or more -- which is a smart strategy for generating above-average returns -- then a single month's results will merely amount to a blip in your portfolio's performance. And over the long haul, both Vertex and Veeva have what it takes to beat the market despite their recent poor performance.
Source Fool.com